Lau, J., Bloch, P., Schffer, L., Pettersson, I., Spetzler, J., Kofoed, J., Madsen, K., Knudsen, L
However, only those drugs that modulate LPL activity (e.g., fibrates, nicotinic acid) were revised here
Drug Class Analysis GLP-1 Weight Loss Drug Market by Drug Class: Injectable and Dual Agonist Therapies Command 78.4% of Revenue Drug Class Revenue Share, CAGR, and Commercial Drivers GLP-1 Obesity Drug Market 2026 Injectable GLP-1 receptor agonist monoagonists hold a 32.8% GLP-1 market revenue share in 2026 , reflecting Wegovys position as the most commercially successful weight management drug in pharmaceutical history
This improvement occurs because increased collagen production helps fill in fine lines and wrinkles from within the skin layers, rather than just temporarily plumping the surface